Hu Li
Affiliations: | Molecular Pharmacology and Experimental Therapeutics | Mayo Clinic College of Medicine and Science |
Google:
"Hu Li"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Yu Zong Chen | grad student | National University of Singapore | |
| James J. Collins | post-doc | MIT | |
| George Q. Daley | post-doc | Harvard Medical School (Chemistry Tree) |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Warrier T, El Farran C, Zeng Y, et al. (2022) SETDB1 acts as a topological accessory to Cohesin via an H3K9me3-independent, genomic shunt for regulating cell fates. Nucleic Acids Research |
| Correia C, Weiskittel TM, Ung CY, et al. (2022) Uncovering Pharmacological Opportunities for Cancer Stem Cells-A Systems Biology View. Frontiers in Cell and Developmental Biology. 10: 752326 |
| Wen T, Barham W, Li Y, et al. (2021) NKG7 is a T-cell intrinsic therapeutic target for improving antitumor cytotoxicity and cancer immunotherapy. Cancer Immunology Research |
| Sun Z, Yu H, Zhao J, et al. (2021) LIN28 coordinately promotes nucleolar/ribosomal functions and represses the 2C-like transcriptional program in pluripotent stem cells. Protein & Cell |
| Monie DD, Correia C, Zhang C, et al. (2021) Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas. Scientific Reports. 11: 11198 |
| Monie DD, Bhandarkar AR, Parney IF, et al. (2021) Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurgical Focus. 50: E10 |
| Aggen DH, Ager CR, Obradovic AZ, et al. (2020) Blocking Interleukin-1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multi-Dimensional Analyses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wang HF, Warrier T, Farran CA, et al. (2020) Defining Essential Enhancers for Pluripotent Stem Cells Using a Features-Oriented CRISPR-Cas9 Screen. Cell Reports. 33: 108309 |
| Xing QR, El Farran CA, Gautam P, et al. (2020) Diversification of reprogramming trajectories revealed by parallel single-cell transcriptome and chromatin accessibility sequencing. Science Advances. 6 |
| Xing QR, El Farran CA, Zeng YY, et al. (2020) Parallel bimodal single-cell sequencing of transcriptome and chromatin accessibility. Genome Research |